Susquehanna International Group
GENE

Susquehanna International Group’s Genetic Technologies Ltd. GENE Stock Holding History

Susquehanna International Group’s Portfolio GENE Stock Details GENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,360
Closed -$23K – 14231
2022
Q1 		$23K Sell
2,360
-3,320
-58% -$32.3K ﹤0.01% 12587
2021
Q4 		$53K Sell
5,680
-1,700
-23% -$21.8K ﹤0.01% 12517
2021
Q3 		$114K Sell
7,380
-5,600
-43% -$96.1K ﹤0.01% 11979
2021
Q2 		$276K Buy
12,980
+2,500
+24% +$50.4K ﹤0.01% 10960
2021
Q1 		$219K Sell
10,480
-3,360
-24% -$76.9K ﹤0.01% 11245
2020
Q4 		$249K Buy
13,840
+2,700
+24% +$44.6K ﹤0.01% 9656
2020
Q3 		$193K Buy
+11,140
New +$208K ﹤0.01% 9485

Other funds holding GENE

RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Susquehanna International Group's GENE Position: Q4 2024 in Review

Susquehanna International Group sold out of Genetic Technologies Ltd. (GENE) in Q4 2024, closing a stake of 27,617 shares — an estimated $20.7K sold.

Susquehanna International Group first reported a position in GENE in Q2 2013 and held it in 25 quarters. The position peaked at $997K in Q4 2016. 1 fund tracked by Wall St. Rank holds GENE as of Q4 2024.

  • Susquehanna International Group reported no remaining Genetic Technologies Ltd. position as of Q4 2024 after selling out during the quarter.
  • Susquehanna International Group sold 27,617 Genetic Technologies Ltd. shares in Q4 2024, an estimated $20.7K.
  • Susquehanna International Group first reported a position in Genetic Technologies Ltd. in Q2 2013 and held it in 25 quarters.
  • Susquehanna International Group's Genetic Technologies Ltd. position peaked at $997K in Q4 2016.
  • 1 fund tracked by Wall St. Rank held Genetic Technologies Ltd. as of Q4 2024.

Based on Susquehanna International Group's 13F filing for Q4 2024, filed 14 Feb 2025.